. | . |
Hungary cools on Russian Covid jab, scolds EU on vaccines by AFP Staff Writers Budapest (AFP) Jan 3, 2021 Hungary is unlikely to use Russia's coronavirus vaccine due to its limited production capacity, Prime Minister Viktor Orban said Sunday while criticising the EU's vaccine acquisition approach. Often at loggerheads with Brussels over democratic standards, Orban has sent experts to monitor vaccine development in Russia and China, and received samples of Moscow's controversial Sputnik V jab. "We know that the Russian vaccine is good, but there is not enough of it and probably will not be, as there are production capacity limits," Orban said in an interview on Hungarian public radio. In comparison with Sputnik V "the Chinese (vaccine) is more promising, it seems that it will be available sooner and in greater quantities," said Orban. "Ideally, you will be able to choose whether you want to vaccinate yourself with either a vaccine from the west or a Chinese vaccine," he said. In November Budapest boasted that Hungary was the first European country to receive test samples of the Russian vaccine. Western and Russian experts have raised concerns over the fast-tracked drug, which has not yet been approved for marketing inside the bloc by the EU's European Medicines Agency (EMA). Critics have also described Sputnik V as a tool to bolster Russia's geopolitical influence. Orban said Sunday however that he is "not happy with the pace" of vaccine acquisition from the EU. "There were manufacturers whose products were available sooner in Canada, the UK, and in Israel than for example in the EU," he said. "But that is Brussels' job, they are dealing with it," he added. "We are looking after the eastern relations contact network, as Brussels is not doing that.., that is why it is better to stand on two legs," he said. Orban's latest jibe toward Brussels comes after Hungary sidestepped the EU's coordinated approach to vaccinations last week. After receiving its first delivery of the Belgian-made Pfizer-BioNTech coronavirus jab December 26 it immediately started administering the vaccine, sidestepping the EU's joint start that began a day later.
Asian tiger mosquito presents limited risk for Zika virus outbreaks Washington DC (UPI) Dec 31, 2020 The Asian tiger mosquito poses only a minor risk for Zika virus, according to new epidemiological simulations. The yellow fever mosquito Aedes aegypti is the primary vector for Zika virus, the infectious disease that can spread from mother to fetus, causing congenital deformities. However, lab experiments have previously shown the Asian tiger mosquito Aedes albopictus can carry and transmit the disease. In 2019, scientists in France blamed several instances of Zika infection and t ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |